Meeting
2014 ASCO Annual Meeting
Acute toxicity in African American and Caucasian patients with adjuvant/neoadjuvant chemotherapy for breast cancer.
Authors
Mansoor Ul Haq
University of Tennessee Health Sciences Center, Memphis, TN
Mansoor Ul Haq , Namratha Vontela , Pranitha Naini , Jessica N. Snider , Mark S. Walker , Lee Steven Schwartzberg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy
Track
Breast Cancer
Sub Track
Cytotoxic Chemotherapy
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 1059)
DOI
10.1200/jco.2014.32.15_suppl.1059
Abstract #
1059
Poster Bd #
152
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Real world study of racial disparities associated with toxicities of sacituzumab govitecan.
First Author: Shista Priyadarshini
Poster
2020 ASCO Virtual Scientific Program
Basal subtype and clinical estrogen receptor status of genomically basal breast tumors in Caucasian, African American, and Latin American patients.
First Author: Virginia G. Kaklamani
Poster
2016 ASCO Annual Meeting
Combined effect of obesity and comorbidity on toxicity of adjuvant chemotherapy for breast cancer (BC).
First Author: Ana Fernandez Sanchez
Poster
2015 ASCO Annual Meeting
A Phase II study of cabozantinib for metastatic triple-negative breast cancer (TNBC).
First Author: Sara M. Tolaney